Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6917 stock hub

TPEX/6917 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6917is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.7B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6917

In the news

Latest news · TPEX/6917

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROEn/a

P25 -16.2P50 0.3P75 9.8

ROICn/a

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6917 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

Groups with data

Currency

TWD

Showing 82 of 82 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0006917008
Last refreshed	2026-05-10
Market cap	TWD 1.7B
Price	TWD 38
Price currency	TWD
Sector	Healthcare
Sic	2836
Symbol	tpex/6917
Website	https://www.andros.com.tw

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	126.44%
Cagr3y	4.25%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
WACC	8.74

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	126.31%
200-day SMA	23.05
3Y total return	13.29%
50-day SMA	28.1
50-day SMA vs 200-day SMA	50over200
All Time High	46.3
All Time High Change	-17.93%
All Time High Date	2023-01-12
All Time Low	13.85
All Time Low Change	174.37%
All Time Low Date	2025-04-09
ATR	2.43
Beta	0.82
Beta1y	-0.03
Beta2y	0.35
Ch YTD	56.38
High	39.65
High52	45.95
High52 Date	2026-04-21
High52ch	-17.3%
Low	36.5
Low52	15.7
Low52 Date	2025-06-11
Low52ch	142.04%
Ma50ch	35.25%
Price vs 200-day SMA	64.84%
RSI	60.16
RSI Monthly	71.75
RSI Weekly	76.84
Sharpe ratio	1.72x
Sortino ratio	3.62
Tr YTD	56.38
Tr1m	52%
Tr1w	-3.31%
Tr3m	61.02%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34,176,889%
Shares Insiders	5.22%
Shares Institutions	15.42%
Shares Out	45,372,000

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,400,429.65x
Ch1m	52
Ch1w	-3.31
Ch1y	119
Ch3m	61.02
Ch3y	7.19
Ch6m	73.91
Change	-5.24%
Change From Open	-4.04
Close	40.1
Days Gap	-1.25
Dollar Volume	40,138,982
F Score	0
Founded	2,008
Is Primary Listing	1
Ma150	24.7
Ma150ch	53.85%
Ma20	36.49
Ma20ch	4.14%
Open	39.6
Position In Range	47.62
Price Date	2026-05-08
Relative Volume	0.78x
Tr6m	73.91%
Volume	1,056,289

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/6917 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6917 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6917?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.4%

Share of float held by funds and institutions

Insider ownership

+5.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TPEX/6917 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.2

Neutral momentum band

Price vs 200-day MA

+64.8%

50/200-day relationship not available

Beta (5Y)

0.82

Moves roughly with the market

Sharpe ratio

1.72

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6917

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6917 stock rating?

tpex/6917 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6917 analysis?

The full report lives at /stocks/tpex/6917/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6917?

The latest report frames tpex/6917 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6917 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.